Preveceutical Medical Inc C.PREV

Alternate Symbol(s): PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its BSV peptide program targets cancer progression. Its Non-Addictive Analgesic is an engineering non-addictive analgesic peptide for pain management. Its Dual Gene Therapy targets type 2 diabetes and obesity. The Company’s subsidiary, PreveCeutical (Australia) Pty Ltd., manages its research programs.

CSE:PREV - Post by User

Preveceutical Medical Inc

Bullboard Posts

Post by Gorbtrukon Apr 06, 2019 5:36pm

280 Views

Post# 29592510

Brace yourselves

Just a little side note not related to the recent great news that was released.

 	 Stephen Van Deventer, a seasoned business person and venture capitalist and Kimberly Van Deventer, a successful entrepreneur met in 2009 and formed a business partnership. This was a great meeting of minds. In 2010 they started Cornerstone Global Partners, a venture capital, and business development company. They were involved in a number of ventures and building companies. One of those companies was ACB...Aurora Cannabis..
 	
 	Prev helped ACB with the start up funding they needed to get going. That kinda favour is never forgotten.
 	
 	GG gorbo